Media headlines about Balchem (NASDAQ:BCPC) have trended somewhat positive on Saturday, according to Accern. The research group rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Balchem earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned news stories about the basic materials company an impact score of 46.5614845182987 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Separately, BidaskClub downgraded Balchem from a “sell” rating to a “strong sell” rating in a report on Friday, December 22nd.
Shares of Balchem (BCPC) opened at $82.07 on Friday. The company has a current ratio of 1.84, a quick ratio of 1.28 and a debt-to-equity ratio of 0.31. Balchem has a fifty-two week low of $70.23 and a fifty-two week high of $88.47. The firm has a market capitalization of $2,608.41, a price-to-earnings ratio of 29.42 and a beta of 1.05.
ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Balchem (BCPC) Share Price” was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://sportsperspectives.com/2018/03/17/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-balchem-bcpc-share-price.html.
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.